A5003229644- HIV, Drug Use, Sexual Risk
- HIV/AIDS Research and Interventions
- Sex work and related issues
- Reproductive tract infections research
- Syphilis Diagnosis and Treatment
- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Bacterial Infections and Vaccines
- Tuberculosis Research and Epidemiology
- Respiratory viral infections research
- Hepatitis B Virus Studies
- HIV/AIDS Impact and Responses
- Influenza Virus Research Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Adolescent Sexual and Reproductive Health
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
- Global Public Health Policies and Epidemiology
- HIV Research and Treatment
- COVID-19 epidemiological studies
- Data-Driven Disease Surveillance
- Migration, Health and Trauma
- Infectious Diseases and Tuberculosis
- SARS-CoV-2 and COVID-19 Research
- Indoor Air Quality and Microbial Exposure
European Centre for Disease Prevention and Control
2014-2025
Saudi Center for Disease Prevention and Control
2024
TuBerculosis Vaccine Initiative
2016
Primary HealthCare
2007
Surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in Europe is performed through the European Gonococcal Antimicrobial Programme (Euro-GASP), which additionally provides data to inform gonorrhoea treatment guideline; currently recommending ceftriaxone 500 mg plus azithromycin 2 g as first-line therapy. We present from 24 countries 2015, linked epidemiological patients, and compare results Euro-GASP previous years.Antimicrobial testing by MIC gradient strips or agar dilution...
Between weeks 40 2020 and 8 2021, the World Health Organization European Region experienced a 99.8% reduction in sentinel influenza virus positive detections (33/25,606 tested; 0.1%) relative to an average of 14,966/39,407 (38.0%; p < 0.001) over same time previous six seasons. COVID-19 pandemic public health physical distancing measures may have extinguished 2020/21 seasonal epidemic with just few sporadic all viral subtypes. This might possibly continue during remainder season.
Migrants are considered a key group at risk for HIV infection. This study describes the epidemiology of and distribution late presentation among migrants within European Union/European Economic Area during 2007-2012.HIV cases reported to Surveillance System (TESSy) were analyzed. defined as people whose geographical origin was different than reporting country. Multiple logistic regression used model presentation.Overall, 156,817 reported, which 60,446 (38%) migrants. Of these, 53% from...
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the Union/European Economic Area (EU/EEA). We present Euro-GASP results from 2016 (25 countries), linked patient epidemiological data, and compared with data previous years. Agar dilution minimum inhibitory concentration (MIC) gradient strip methodologies were used determine antimicrobial...
In the European Union/European Economic Area (EU/EEA), migrants from high-endemic countries are disproportionately affected by HIV. Between 2007 and 2012, represented 39 % of reported HIV cases. There is growing evidence that a significant proportion acquisition among migrant populations occurs after their arrival in Europe. Migrants confronted with multiple risk factors shape patterns population susceptibility vulnerability, which simultaneously affect transmission. Undocumented incur...
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the Union/European Economic Area (EU/EEA). We present Euro-GASP results from 2019 (26 countries), linked patient epidemiological data, and compared with data previous years.Agar dilution minimum inhibitory concentration (MIC) gradient strip methodologies were used determine antimicrobial (using...
Since June 2012, 133 Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been identified in nine countries. Two time periods 2013 were compared to identify changes the epidemiology. The case-fatality risk (CFR) is 45% and decreasing. Men a higher CFR (52%) are over-represented among cases. Thirteen out of 14 known primary died. sex-ratio more balanced latter period. Nosocomial transmission was implied 26%
Preview this article: Tick-borne encephalitis joins the diseases under surveillance in European Union, Page 1 of < Previous page | Next > /docserver/preview/fulltext/eurosurveillance/17/42/art20299-en-1.gif
Objectives Understanding the public health impact of lymphogranuloma venereum (LGV) in Europe is hampered by inadequate diagnostics and surveillance systems many European countries. We developed piloted LGV three countries without existing performed a preliminary investigation epidemiology, where little evidence currently exists. Methods recruited STI or dermatovenereology clinics associated laboratories serving men who have sex with (MSM) Austria, Croatia Slovenia, using UK for comparison....
Since 2011, human immunodeficiency virus (HIV) incidence appears unchanged in the European Union/European Economic Area with between 29,000 and 33,000 new cases reported annually up to 2015. Despite evidence that HIV diagnosis is occurring earlier post-infection, estimated number of people living (PLHIV) who were unaware being infected 2015 was 122,000, or 15% all PLHIV (n=810,000). This concerning as such individuals cannot benefit from highly effective treatment may unknowingly sustain...
In 2018, 52 of 55 European and Central Asian countries reported data against the UNAIDS 90–90–90 targets. Overall, 80% people living with HIV (PLHIV) were diagnosed, whom 64% received treatment 86% treated virally suppressed. Subregional outcomes varied: West (87%–91%–93%), Centre (83%–73%–75%) East (76%–46%–78%). 43% all PLHIV suppressed; intensive efforts are needed to meet 2020 target 73%.
The European Gonococcal Antimicrobial Surveillance Programme performs antimicrobial resistance surveillance and is coordinated by the Centre for Disease Prevention Control. This study used epidemiological behavioral data combined with gonococcal susceptibility profiles to determine risk factors associated harboring resistant gonococci in Europe.From 2009 2011, isolates from 21 countries were submitted testing. Patient variables azithromycin, cefixime, ciprofloxacin identified using...
Abstract Background European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) antimicrobial resistance (AMR) data are used to inform gonorrhoea treatment guidelines; therefore the need be robust and representative. We assessed extent which Euro-GASP reflects national measures of AMR situation for Neisseria gonorrhoeae across Union/European Economic Area (EU/EEA). Methods compared from with published gonococcal 15 countries azithromycin, cefixime ciprofloxacin period 2009 2013...
This article presents the steps and considerations that led to development of European Centre for Disease Prevention Control s (ECDC) long-term strategy surveillance communicable diseases in Union (EU) years 2008 2013. Furthermore, it outlines key features was approved by ECDC Management Board December 2007.
Background: In 2012, the levels of chlamydia control activities including primary prevention, effective case management with partner and surveillance were assessed in 2012 across countries European Union Economic Area (EU/EEA), on initiative Centre for Disease Control (ECDC) survey, findings compared those from a similar survey 2007. Methods: Experts 30 EU/EEA invited to respond an online questionnaire; 28 responded, which 25 participated both 2007 surveys. Analyses focused 13 indicators...
Because cefixime and ceftriaxone resistance in Neisseria gonorrhoeae gonorrhoea treatment failures were increasing, a response plan to control manage multidrug-resistant N. (MDR-NG) Europe was published 2012. The three main areas of the to: (i) strengthen surveillance antimicrobial (AMR), (ii) implement monitoring (iii) establish communication strategy increase awareness disseminate AMR results. Since 2012, several additional extensively drug-resistant (XDR-NG) strains have emerged, with...
An analysis of surveillance data was performed to assess treatment outcomes patients belonging selected calendar year cohorts. Twenty-two countries in the European Union (EU) and Economic Area (EEA) reported outcome monitoring for culture-confirmed pulmonary tuberculosis (TB) cases 2007. The overall success rate 73.8% all 79.5% new cases. For cohort TB cases, only three achieved target 85% rate. This underachievement appears be a result relative high defaulting unknown information. Case...